Doctor's visit | price on request |
Vagus nerve stimulation | $48601.62 - $50761.7 |
Stereotaxic surgeries | $27000.9 - $70202.34 |
Deep brain stimulation (DBS) surgery |
Dr. Rodrigo Rocamora Zuniga is a renowned neurologist, head of the epilepsy department at HM Delfos Spain and professor at UPF university. He has a PhD from Bonn University, a specialization in neurology from Pontificia Universidad Católica de Chile, and a medical bachelor from Mendoza school of medical in Argentina. He has also been part of neurology centers and hospitals, leading doctor of several professional organizations, and has published in various journals.
Read moreDr. Rodrigo Rocamora Zuniga is a renowned neurologist, head of the epilepsy department at HM Delfos Spain and professor at UPF university. He has a PhD from Bonn University, a specialization in neurology from Pontificia Universidad Católica de Chile, and a medical bachelor from Mendoza school of medical in Argentina. He has also been part of neurology centers and hospitals, leading doctor of several professional organizations, and has published in various journals.
20 top ranked Epilepsy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Epilepsy doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Epilepsy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Epilepsy varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Epilepsy if you have any difficulties with a choice. Bookimed services are free for patients ♥
Pathologies
-Benign brain tumors: meningiomas and neuromas:
-Cerebral vascular malformations:
-Obsessive-compulsive disorder treatment operations:
-Operations to combat nervous anorexia:
Publications
2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,
2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.
2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757
2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.
2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur
2022| Radiosurgery for Mental Disorders LGKA Marsella
2022| The Role of SRS in Anorexia Nervosa ISRS Milan
2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia
2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo
Awards and certificates
2019|National Medical Prize XXI in the field of neurosurgery.
2018 | Editorial Board Member, American Journal of Psychiatry and Neurology
2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery
2012 | Correspondent of the Real Medical Academy of Asturias.
Read morePathologies
-Benign brain tumors: meningiomas and neuromas:
-Cerebral vascular malformations:
-Obsessive-compulsive disorder treatment operations:
-Operations to combat nervous anorexia:
Publications
2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,
2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.
2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757
2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.
2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur
2022| Radiosurgery for Mental Disorders LGKA Marsella
2022| The Role of SRS in Anorexia Nervosa ISRS Milan
2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia
2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo
Awards and certificates
2019|National Medical Prize XXI in the field of neurosurgery.
2018 | Editorial Board Member, American Journal of Psychiatry and Neurology
2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery
2012 | Correspondent of the Real Medical Academy of Asturias.
Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.
More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.
The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.
Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.
He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).
Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.
In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.
In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).
Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.
Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.
Read moreSince 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.
More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.
The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.
Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.
He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).
Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.
In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.
In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).
Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.
Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.
Specialist in Neurology
Head of the Advanced Neurosciences Unit – Quirónsalud
Head of the Neurology Service
Hospital Universitario de Torrevieja (2018 – 2021)
Led a multidisciplinary neurology team with a focus on patient-centered care, especially for neurodegenerative disorders.
Head of Neurology Service
Hospital Clínica Benidorm (2017 – 2018)
Oversaw diagnostic and therapeutic services in general neurology, epilepsy, and movement disorders.
Consultant Neurologist
Hospital General Universitario de Alicante (2017 – 2018)
Specialized in inpatient and outpatient neurology services, actively participated in teaching and research.
Consultant Neurologist
Hospital de Manises, Valencia (2016 – 2017)
Focus on epilepsy and complex neurological diagnostics.
General Practitioner
Baghavatula Charitable Trust (BCT), Vishakapatnam, India (2012 – 2016)
Provided healthcare services in underserved rural communities, gaining valuable experience in global medicine.
Medical Degree
Universidad Autónoma de Madrid (UAM) (2005 – 2011)
Neurology Residency (MIR Program)
Hospital General Universitario de Alicante (2012 – 2016)
Postgraduate Specialization in Movement Disorders
Universidad Oberta de Catalunya (2019 – 2020)
Postgraduate Specialization in Clinical Research
Chair UAM-Abbvie (2020 – ongoing)
Master in Healthcare Management
UDIMA - Universidad a Distancia de Madrid (2020 – ongoing)
Master in Clinical Neurology
Universidad Francisco de Vitoria (2020 – ongoing)
Member of the Valencian Society of Neurology (SVN)
Member of the Spanish Society of Neurology (SEN)
Publications:
"Creutzfeldt-Jakob Disease – Heidenhain Variant" – Presented at the 66th Meeting of the Spanish Society of Neurology (2015)
"Sleepwalking or Epilepsy?" – Presented at the 39th Annual Meeting of the Spanish Society of Neuropediatrics (2016)
Conferences & Courses:
Epilepsy Hospital Stage Course – Hospital La Princesa, Madrid (2020)
Updates on Parkinson’s Disease and Movement Disorders – Movement Disorder Society, 2019
American Epilepsy Society Annual Meeting – Baltimore, USA (2019)
Read moreSpecialist in Neurology
Head of the Advanced Neurosciences Unit – Quirónsalud
Head of the Neurology Service
Hospital Universitario de Torrevieja (2018 – 2021)
Led a multidisciplinary neurology team with a focus on patient-centered care, especially for neurodegenerative disorders.
Head of Neurology Service
Hospital Clínica Benidorm (2017 – 2018)
Oversaw diagnostic and therapeutic services in general neurology, epilepsy, and movement disorders.
Consultant Neurologist
Hospital General Universitario de Alicante (2017 – 2018)
Specialized in inpatient and outpatient neurology services, actively participated in teaching and research.
Consultant Neurologist
Hospital de Manises, Valencia (2016 – 2017)
Focus on epilepsy and complex neurological diagnostics.
General Practitioner
Baghavatula Charitable Trust (BCT), Vishakapatnam, India (2012 – 2016)
Provided healthcare services in underserved rural communities, gaining valuable experience in global medicine.
Medical Degree
Universidad Autónoma de Madrid (UAM) (2005 – 2011)
Neurology Residency (MIR Program)
Hospital General Universitario de Alicante (2012 – 2016)
Postgraduate Specialization in Movement Disorders
Universidad Oberta de Catalunya (2019 – 2020)
Postgraduate Specialization in Clinical Research
Chair UAM-Abbvie (2020 – ongoing)
Master in Healthcare Management
UDIMA - Universidad a Distancia de Madrid (2020 – ongoing)
Master in Clinical Neurology
Universidad Francisco de Vitoria (2020 – ongoing)
Member of the Valencian Society of Neurology (SVN)
Member of the Spanish Society of Neurology (SEN)
Publications:
"Creutzfeldt-Jakob Disease – Heidenhain Variant" – Presented at the 66th Meeting of the Spanish Society of Neurology (2015)
"Sleepwalking or Epilepsy?" – Presented at the 39th Annual Meeting of the Spanish Society of Neuropediatrics (2016)
Conferences & Courses:
Epilepsy Hospital Stage Course – Hospital La Princesa, Madrid (2020)
Updates on Parkinson’s Disease and Movement Disorders – Movement Disorder Society, 2019
American Epilepsy Society Annual Meeting – Baltimore, USA (2019)